Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response

Molecular Immunology

Volumn 46, Issue 8-9, 2009, Pages 1718-1726

  Li, Shenghua ^a   Zheng, Wenju ^a   KuoLee, Rhonda ^a   Hirama, Tomoko ^a   Henry, Matthew ^b   Makvandi Nejad, Shokouh ^c   Fjällman, Ted ^d   Chen, Wangxue ^a   Zhang, Jianbing ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b DOW AGROSCIENCES LLC   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

^d Beijer Intl Inst of Ecol Econ   (Sweden)

Author keywords

CT; CTB; Mucosal immunization; Single domain antibody

Indexed keywords

BOVINE SERUM ALBUMIN; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENHANCER REGION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; CAMELIDS, NEW WORLD; CHOLERA TOXIN; DRUG DELIVERY SYSTEMS; EPITOPES; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SERUM ALBUMIN, BOVINE;

ANIMALIA; BOVINAE; ESCHERICHIA COLI; LAMA (MAMMAL); MUS;

EID: 64149084018     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.02.007     Document Type: Article

References (38)

1. Agren L.C., Ekman L., Lowenadler B., Nedrud J.G., and Lycke N.Y. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity. J. Immunol. 162 (1999) 2432-2440
2. Arbabi Ghahroudi M., Desmyter A., Wyns L., Hamers R., and Muyldermans S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 414 (1997) 521-526
3. Boyaka P.N., Ohmura M., Fujihashi K., Koga T., Yamamoto M., Kweon M.N., Takeda Y., Jackson R.J., Kiyono H., Yuki Y., and McGhee J.R. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit. J. Immunol. 170 (2003) 454-462
4. Davies J., and Riechmann L. Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding. Immunotechnology 2 (1996) 169-179
5. De Genst E., Handelberg F., Van Meirhaeghe A., Vynck S., Loris R., Wyns L., and Muyldermans S. Chemical basis for the affinity maturation of a camel single domain antibody. J. Biol. Chem. 279 (2004) 53593-53601
6. Dickinson B.L., and Clements J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63 (1995) 1617-1623
7. Douce G., Fontana M., Pizza M., Rappuoli R., and Dougan G. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect. Immun. 65 (1997) 2821-2828
8. Drake A.W., Myszka D.G., and Klakamp S.L. Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods. Anal. Biochem. 328 (2004) 35-43
9. Dumoulin M., Conrath K., Van Meirhaeghe A., Meersman F., Heremans K., Frenken L.G., Muyldermans S., Wyns L., and Matagne A. Single-domain antibody fragments with high conformational stability. Protein Sci. 11 (2002) 500-515
10. Eriksson K., Fredriksson M., Nordstrom I., and Holmgren J. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect. Immun. 71 (2003) 1740-1747
11. Giuliani M.M., Del Giudice G., Giannelli V., Dougan G., Douce G., Rappuoli R., and Pizza M. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J. Exp. Med. 187 (1998) 1123-1132
12. Gockel C.M., and Russell M.W. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein. Immunology 116 (2005) 477-486
13. Greenberg A.S., Avila D., Hughes M., Hughes A., McKinney E.C., and Flajnik M.F. A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 374 (1995) 168-173
14. Guy B., Hessler C., Fourage S., Haensler J., Vialon-Lafay E., Rokbi B., and Millet M.J. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16 (1998) 850-856
15. Haan L., Verweij W.R., Holtrop M., Brands R., van Scharrenburg G.J., Palache A.M., Agsteribbe E., and Wilschut J. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. Vaccine 19 (2001) 2898-2907
16. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., and Hamers R. Naturally occurring antibodies devoid of light chains. Nature 363 (1993) 446-448
17. Harakuni T., Sugawa H., Komesu A., Tadano M., and Arakawa T. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infect. Immun. 73 (2005) 5654-5665
18. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 11 (2005) S45-53
19. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl. 2 (2003) S89-S95
20. Kang S.M., Guo L., Yao Q., Skountzou I., and Compans R.W. Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens. J. Virol. 78 (2004) 9624-9632
21. Kawamura Y.I., Kawashima R., Shirai Y., Kato R., Hamabata T., Yamamoto M., Furukawa K., Fujihashi K., McGhee J.R., Hayashi H., and Dohi T. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation. Eur. J. Immunol. 33 (2003) 3205-3212
22. Lebens M., Sun J.B., Sadeghi H., Backstrom M., Olsson I., Mielcarek N., Li B.L., Capron A., Czerkinsky C., and Holmgren J. A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection. Vaccine 21 (2003) 514-520
23. Matoba N., Geyer B.C., Kilbourne J., Alfsen A., Bomsel M., and Mor T.S. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR (649-684), a mucosal subunit HIV/AIDS vaccine candidate. Vaccine 24 (2006) 5047-5055
24. McCluskie M.J., and Davis H.L. CpG DNA as mucosal adjuvant. Vaccine 18 (1999) 231-237
25. Patel G.B., Zhou H., Ponce A., and Chen W. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Vaccine 25 (2007) 8622-8636
26. Revesz T., Greaves M.F., Capellaro D., and Murray R.K. Differential expression of cell surface binding sites for cholera toxin in acute and chronic leukaemias. Br. J. Haematol. 34 (1976) 623-630
27. Revets H., De Baetselier P., and Muyldermans S. Nanobodies as novel agents for cancer therapy. Expert Opin. Biol. Ther. 5 (2005) 111-124
28. Sakaue G., Hiroi T., Nakagawa Y., Someya K., Iwatani K., Sawa Y., Takahashi H., Honda M., Kunisawa J., and Kiyono H. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J. Immunol. 170 (2003) 495-502
29. Schulze K., Medina E., Chhatwal G.S., and Guzman C.A. Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein. Vaccine 21 (2003) 1958-1964
30. Stone E., Hirama T., Chen W., Soltyk A.L., Brunton J., MacKenzie C.R., and Zhang J. A novel pentamer versus pentamer approach to generating neutralizers of verotoxin 1. Mol. Immunol. 44 (2007) 2487-2491
31. Stone E., Hirama T., Tanha J., Tong-Sevinc H., Li S., MacKenzie C.R., and Zhang J. The assembly of single domain antibodies into bispecific decavalent molecules. J. Immunol. Methods 318 (2007) 88-94
32. Tanha J., Muruganandam A., and Stanimirovic D. Phage display technology for identifying specific antigens on brain endothelial cells. Methods Mol. Med. 89 (2003) 435-449
33. Tsuji T., Yokochi T., Kamiya H., Kawamoto Y., Miyama A., and Asano Y. Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action. Immunology 90 (1997) 176-182
34. Vaughan M., and Moss J. Mechanism of action of choleragen. J. Supramol. Struct. 8 (1978) 473-488
35. Walsh E.E. Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice. Vaccine 11 (1993) 1135-1138
36. Yamamoto S., Takeda Y., Yamamoto M., Kurazono H., Imaoka K., Yamamoto M., Fujihashi K., Noda M., Kiyono H., and McGhee J.R. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J. Exp. Med. 185 (1997) 1203-1210
37. Zhang J., Li Q., Nguyen T.D., Tremblay T.L., Stone E., To R., Kelly J., and Roger MacKenzie C. A pentavalent single-domain antibody approach to tumor antigen discovery and the development of novel proteomics reagents. J. Mol. Biol. 341 (2004) 161-169
38. Zhang J., Tanha J., Hirama T., Khieu N.H., To R., Tong-Sevinc H., Stone E., Brisson J.R., and MacKenzie C.R. Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J. Mol. Biol. 335 (2004) 49-56